サンプル依頼リスト カート
  • English
  • Korean
表紙：関節痛注射の世界市場規模調査・予測、注射タイプ別、関節タイプ別、流通チャネル別、地域別分析、2022-2029年
市場調査レポート
商品コード
1215418

関節痛注射の世界市場規模調査・予測、注射タイプ別、関節タイプ別、流通チャネル別、地域別分析、2022-2029年

Global Joint Pain Injections Market Size study & Forecast, by Injection Type, by Joint Type, by Distribution Channel and Regional Analysis, 2022-2029
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
関節痛注射の世界市場規模調査・予測、注射タイプ別、関節タイプ別、流通チャネル別、地域別分析、2022-2029年
出版日: 2023年02月08日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

関節痛注射の世界市場は、2021年に約63億米ドルと評価され、予測期間2022-2029年には7.7%以上の健全な成長率で成長すると予想されています。

関節痛の注射は、痛みを和らげ、炎症や腫れを最小限に抑えるために、関節に直接投与されます。関節痛は、通常、高齢者において既存の疾患や症状の結果として発生します。関節炎は、主に膝、足首、股関節、肩、肘、脊椎の小関節に発生し、炎症を起こして関節の不快感を増大させる関節痛を引き起こす一般的な疾患です。変形性関節症や関節リウマチの有病率の増加、手頃な価格の治療ソリューションへのニーズの高まり、また事故による負傷率の上昇などが、市場の成長を加速させる主な要因となっています。

変形性関節症と関節リウマチの有病率の上昇は、世界の関節痛注射剤市場の成長に寄与しています。例えば、The Arthritis Foundationの推計によると-2019年現在、米国では約9100万人以上の成人が関節炎を患って生活しており、その数は2040年までに1億1300万人に達すると保護されています。さらに、医師から関節炎と診断された米国の成人の数は7840万人に増加し、関節炎による活動制限を訴える人の数は、2040年までに3460万人に増加すると見られています。また、老年人口が増加し、新興国の医療インフラが整備されることで、予測期間中に市場が有利に成長する見通しが立っています。しかし、治療認可のための厳しい規制の枠組みが、2022年から2029年の予測期間を通じて市場の成長を阻害します。

世界の関節痛注射市場調査のために考慮された主要地域は、アジア太平洋、北米、欧州、中南米、世界のその他の地域が含まれています。北米は、主要な市場プレイヤーの優位性と地域における関節炎の有病率の増加により、収益の面で市場を独占しています。一方、アジア太平洋地域は、老年人口および対象人口の増加、受託製造組織の拡大、同地域における大手市場プレイヤーの浸透の増加などの要因から、予測期間中に最高のCAGRで成長すると予想されます。

本調査の目的は、近年における様々なセグメントと国の市場規模を定義し、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的な側面を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細な情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場の潜在的な機会も組み込んでいます。

注射剤タイプ別

インターロイキンインヒビター

ヒアルロン酸注射

関節タイプ別

膝関節および足関節

股関節

肩・肘関節

背骨のファセット関節

販売チャネル別

病院薬局

ドラッグストア・小売店

オンラインショップ

目次

第1章 エグゼクティブサマリー

  • 市場スナップショット
  • 世界・セグメント別市場推定・予測、2019年～2029年
    • 関節痛用注射剤市場：地域別、2019-2029年
    • 関節痛の注射剤市場：注射剤タイプ別、2019-2029年
    • 関節痛用注射剤市場：関節タイプ別、2019-2029年
    • 関節痛用注射剤市場：流通チャネル別、2019-2029年
  • 主な動向
  • 調査手法
  • 調査前提条件

第2章 関節痛用注射剤の世界市場定義と範囲

  • 調査の目的
  • 市場の定義と範囲
    • 調査対象範囲
    • 産業の進化
  • 調査対象年
  • 通貨換算レート

第3章 関節痛の注射薬の世界市場力学

  • 関節痛の注射薬市場のインパクト分析（2019-2029年）
    • 市場促進要因
      • 変形性関節症および関節リウマチの有病率の増加
      • 手頃な価格の治療ソリューションへのニーズの高まり
      • 事故別負傷率の上昇
    • 市場の課題
      • 厳格な規則性
    • 市場機会
      • 老年人口の増加
      • 発展途上地域におけるヘルスケアインフラの成長

第4章 世界の関節痛注射の市場産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォースモデルへの未来的アプローチ（2019-2029年）
  • PEST分析
    • 政治的
    • 経済的
    • 社会的
    • 技術的
  • トップ投資機会
  • 主要成功戦略
  • 業界専門家別展望
  • アナリストの結論・提言

第5章 リスク評価：COVID-19のインパクト

  • COVID-19が業界に与える全体的な影響の評価
  • COVID-19以前とCOVID-19以後の市場シナリオ

第6章 関節痛用注射剤の世界市場：注射剤タイプ別

  • 市場スナップショット
  • 関節痛の注射の世界市場：注射タイプ別、性能-ポテンシャル分析
  • 関節痛注射の世界市場、注射タイプ別推定・予測2019-2029年
  • 関節痛の注射剤市場、サブセグメント分析
    • インターロイキンインヒビター
    • ヒアルロン酸注射

第7章：関節痛用注射の世界市場：関節タイプ別

  • 市場スナップショット
  • 関節痛注射の世界市場：関節タイプ別性能-ポテンシャル分析
  • 関節痛注射の世界市場、関節タイプ別推定・予測（2019-2029年
  • 関節痛注射の市場、サブセグメント分析
    • 膝関節と足首
    • 股関節
    • 肩・肘関節
    • 背骨のファセット関節

第8章 関節痛用注射剤の世界市場：流通チャネル別

  • 市場スナップショット
  • 関節痛用注射の世界市場：流通チャネル別、実績-ポテンシャル分析
  • 関節痛注射の世界市場、流通チャネル別推定・予測2019-2029年
  • 関節痛用注射薬市場、サブセグメント分析
    • 病院内薬局
    • ドラッグストアと小売薬局
    • オンラインプロバイダー

第9章 関節痛用注射剤の世界市場：地域別分析

  • 関節痛用注射剤の市場、地域別市場スナップショット
  • 北米
    • 米国
      • 注射タイプ別の推定・予測、2019-2029年
      • 関節タイプ別の推定・予測、2019年～2029年
      • 流通チャネル別の推定・予測、2019年～2029年
    • カナダ
  • 欧州の関節痛用注射薬市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他の欧州地域
  • アジア太平洋地域の関節痛治療薬市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカの関節痛治療薬市場スナップショット
    • ブラジル
    • メキシコ
    • その他のラテンアメリカ地域
  • 世界のその他の地域

第10章 競合情報

  • トップ市場戦略
  • 企業プロファイル
    • AbbVie Inc.
      • 主要情報
      • 概要
      • 財務情報（データの入手状況により異なります）
      • 製品概要
      • 最近の動向
    • Anika Therapeutics
    • Bioventus
    • Eli Lilly and Company
    • Ferring Pharmaceuticals Inc.
    • PACIRA BIOSCIENCES（Flexion Therapeutics, Inc.）
    • Pfizer Inc.
    • Sanofi S.A.
    • Teva Pharmaceuticals
    • Zimmer Biomet

第11章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • バリデーション
    • 出版
  • 調査属性
  • 調査の前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Joint Pain Injections Market, report scope
  • TABLE 2. Global Joint Pain Injections Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Joint Pain Injections Market estimates & forecasts by Injection Type 2019-2029 (USD Billion)
  • TABLE 4. Global Joint Pain Injections Market estimates & forecasts by Joint Type 2019-2029 (USD Billion)
  • TABLE 5. Global Joint Pain Injections Market estimates & forecasts by Distribution Channel 2019-2029 (USD Billion)
  • TABLE 6. Global Joint Pain Injections Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Joint Pain Injections Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Joint Pain Injections Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Joint Pain Injections Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Joint Pain Injections Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Joint Pain Injections Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Joint Pain Injections Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Joint Pain Injections Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Joint Pain Injections Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. Global Joint Pain Injections Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Joint Pain Injections Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 17. U.S. Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. U.S. Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 19. Canada Joint Pain Injections Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 20. Canada Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. Canada Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 22. UK Joint Pain Injections Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 23. UK Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. UK Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 25. Germany Joint Pain Injections Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 26. Germany Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. Germany Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 28. France Joint Pain Injections Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 29. France Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. France Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 31. Italy Joint Pain Injections Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 32. Italy Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Italy Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 34. Spain Joint Pain Injections Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 35. Spain Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. Spain Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 37. RoE Joint Pain Injections Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 38. RoE Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. RoE Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 40. China Joint Pain Injections Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 41. China Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. China Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 43. India Joint Pain Injections Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 44. India Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. India Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 46. Japan Joint Pain Injections Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 47. Japan Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. Japan Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 49. South Korea Joint Pain Injections Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 50. South Korea Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. South Korea Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 52. Australia Joint Pain Injections Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 53. Australia Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. Australia Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Joint Pain Injections Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. RoAPAC Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 58. Brazil Joint Pain Injections Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 59. Brazil Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Brazil Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 61. Mexico Joint Pain Injections Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 62. Mexico Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. Mexico Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 64. RoLA Joint Pain Injections Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 65. RoLA Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. RoLA Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 67. Row Joint Pain Injections Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 68. Row Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. Row Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Joint Pain Injections Market
  • TABLE 71. List of primary sources, used in the study of global Joint Pain Injections Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Joint Pain Injections Market, research methodology
  • FIG 2. Global Joint Pain Injections Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Joint Pain Injections Market, key trends 2021
  • FIG 5. Global Joint Pain Injections Market, growth prospects 2022-2029
  • FIG 6. Global Joint Pain Injections Market, porters 5 force model
  • FIG 7. Global Joint Pain Injections Market, pest analysis
  • FIG 8. Global Joint Pain Injections Market, value chain analysis
  • FIG 9. Global Joint Pain Injections Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Joint Pain Injections Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Joint Pain Injections Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Joint Pain Injections Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Joint Pain Injections Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Joint Pain Injections Market, regional snapshot 2019 & 2029
  • FIG 15. North America Joint Pain Injections Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Joint Pain Injections Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Joint Pain Injections Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Joint Pain Injections Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Joint Pain Injections Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Joint Pain Injections Market is valued approximately USD 6.3 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 7.7% over the forecast period 2022-2029. Arthritis injections are given directly into the joints to relieve pain and minimize inflammation and swelling. Joint pain usually occurs in the elderly as a result of pre-existing diseases or conditions. Arthritis is a common disease that mainly occurs in the knee, ankle, hip, shoulder, elbow, and facet joints of the spine, causing joint pain that causes inflammation and increases joint discomfort. The increasing prevalence of osteoarthritis and rheumatoid arthritis and growing need for affordable treatment solutions as well as rising rate of injuries due to accidents are key factors accelerating the market growth.

The rising prevalence of osteoarthritis and rheumatoid arthritis is contributing to the growth of the Global Joint Pain Injections Market. For instance, according to The Arthritis Foundation estimates - as of 2019, approximately more than 91 million adults in the U.S. living with arthritis, and the number is protected to reach to 113 million by 2040. Additionally, the number of adults in the U.S. with doctor-diagnosed arthritis is likely to increase to 78.4 million, and the number of individuals reporting activity limitations due to arthritis would increase to 34.6 million by 2040. Also, rising number of geriatric individuals and growing healthcare infrastructure in developing regions would create lucrative growth prospectus for the market over the forecast period. However, stringent regulatory framework for treatment approval stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Joint Pain Injections Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of leading market players and increasing prevalence of arthritis in the region. Whereas Asia Pacific is expected to grow with a highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, and rising expansion of contract manufacturing organizations, coupled with increasing penetration of leading market players in the region.

Major market players included in this report are:

Abbvie Inc.

Anika Therapeutics

Bioventus

Eli Lilly and Company

Ferring Pharmaceuticals Inc.

PACIRA BIOSCIENCES (Flexion Therapeutics, Inc.)

Pfizer Inc.

Sanofi S.A.

Teva Pharmaceuticals

Zimmer Biomet

Recent Developments in the Market:

  • In July 2019- Tel Aviv, Israel based Teva Pharmaceutical Industries Ltd. has launched 1% Sodium Hyaluronate in the U.S. market after receiving approval from the Center for Devices and Radiological Health of the U.S. FDA. This new product is intended for the treatment of pain associated with osteoarthritis in the knee

Global Joint Pain Injections Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Injection Type, Joint Type, Distribution Channel, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Injection Type

Interleukin Inhibitors

Hyaluronic Acid Injections

By Joint Type

Knee and Ankle

Hip Joint

Shoulder and Elbow

Facet Joints of the Spine

By Distribution Channel

Hospital Pharmacies

Drug Stores and Retail Pharmacies

Online Providers

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

RoLA

Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Joint Pain Injections Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Joint Pain Injections Market, by Injection Type, 2019-2029 (USD Billion)
    • 1.2.3. Joint Pain Injections Market, by Joint Type, 2019-2029 (USD Billion)
    • 1.2.4. Joint Pain Injections Market, by Distribution Channel, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Joint Pain Injections Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Joint Pain Injections Market Dynamics

  • 3.1. Joint Pain Injections Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing prevalence of osteoarthritis and rheumatoid arthritis
      • 3.1.1.2. Growing need for affordable treatment solutions
      • 3.1.1.3. Rising rate of injuries due to accidents
    • 3.1.2. Market Challenges
      • 3.1.2.1. Stringent regularity framework
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising geriatric population
      • 3.1.3.2. Growing healthcare infrastructure in developing regions

Chapter 4. Global Joint Pain Injections Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Joint Pain Injections Market, by Injection Type

  • 6.1. Market Snapshot
  • 6.2. Global Joint Pain Injections Market by Injection Type, Performance - Potential Analysis
  • 6.3. Global Joint Pain Injections Market Estimates & Forecasts by Injection Type 2019-2029 (USD Billion)
  • 6.4. Joint Pain Injections Market, Sub Segment Analysis
    • 6.4.1. Interleukin Inhibitors
    • 6.4.2. Hyaluronic Acid Injections

Chapter 7. Global Joint Pain Injections Market, by Joint Type

  • 7.1. Market Snapshot
  • 7.2. Global Joint Pain Injections Market by Joint Type, Performance - Potential Analysis
  • 7.3. Global Joint Pain Injections Market Estimates & Forecasts by Joint Type 2019-2029 (USD Billion)
  • 7.4. Joint Pain Injections Market, Sub Segment Analysis
    • 7.4.1. Knee and Ankle
    • 7.4.2. Hip Joint
    • 7.4.3. Shoulder and Elbow
    • 7.4.4. Facet Joints of the Spine

Chapter 8. Global Joint Pain Injections Market, by Distribution Channel

  • 8.1. Market Snapshot
  • 8.2. Global Joint Pain Injections Market by Distribution Channel, Performance - Potential Analysis
  • 8.3. Global Joint Pain Injections Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
  • 8.4. Joint Pain Injections Market, Sub Segment Analysis
    • 8.4.1. Hospital Pharmacies
    • 8.4.2. Drug Stores and Retail Pharmacies
    • 8.4.3. Online Providers

Chapter 9. Global Joint Pain Injections Market, Regional Analysis

  • 9.1. Joint Pain Injections Market, Regional Market Snapshot
  • 9.2. North America Joint Pain Injections Market
    • 9.2.1. U.S. Joint Pain Injections Market
      • 9.2.1.1. Injection Type breakdown estimates & forecasts, 2019-2029
      • 9.2.1.2. Joint Type breakdown estimates & forecasts, 2019-2029
      • 9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2019-2029
    • 9.2.2. Canada Joint Pain Injections Market
  • 9.3. Europe Joint Pain Injections Market Snapshot
    • 9.3.1. U.K. Joint Pain Injections Market
    • 9.3.2. Germany Joint Pain Injections Market
    • 9.3.3. France Joint Pain Injections Market
    • 9.3.4. Spain Joint Pain Injections Market
    • 9.3.5. Italy Joint Pain Injections Market
    • 9.3.6. Rest of Europe Joint Pain Injections Market
  • 9.4. Asia-Pacific Joint Pain Injections Market Snapshot
    • 9.4.1. China Joint Pain Injections Market
    • 9.4.2. India Joint Pain Injections Market
    • 9.4.3. Japan Joint Pain Injections Market
    • 9.4.4. Australia Joint Pain Injections Market
    • 9.4.5. South Korea Joint Pain Injections Market
    • 9.4.6. Rest of Asia Pacific Joint Pain Injections Market
  • 9.5. Latin America Joint Pain Injections Market Snapshot
    • 9.5.1. Brazil Joint Pain Injections Market
    • 9.5.2. Mexico Joint Pain Injections Market
    • 9.5.3. Rest of Latin America Joint Pain Injections Market
  • 9.6. Rest of The World Joint Pain Injections Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. AbbVie Inc.
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Anika Therapeutics
    • 10.2.3. Bioventus
    • 10.2.4. Eli Lilly and Company
    • 10.2.5. Ferring Pharmaceuticals Inc.
    • 10.2.6. PACIRA BIOSCIENCES (Flexion Therapeutics, Inc.)
    • 10.2.7. Pfizer Inc.
    • 10.2.8. Sanofi S.A.
    • 10.2.9. Teva Pharmaceuticals
    • 10.2.10. Zimmer Biomet

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption